QCOM
45
2
FDX
74
3
ETR
47
-2
PVH
32
2
NWSA
64
-15
PCG
74
2
UNM
65
-7
DRI
66
2
UHS
55
3
OI
47
-11
SPG
48
2
IP
28
-3
EBAY
53
3
LLY
71
3
TXN
50
2
AN
50
7
TJX
53
-9
MLM
67
4
XYL
33
6
BAX
38
-12
QCOM
45
2
FDX
74
3
ETR
47
-2
PVH
32
2
NWSA
64
-15
PCG
74
2
UNM
65
-7
DRI
66
2
UHS
55
3
OI
47
-11
SPG
48
2
IP
28
-3
EBAY
53
3
LLY
71
3
TXN
50
2
AN
50
7
TJX
53
-9
MLM
67
4
XYL
33
6
BAX
38
-12
Financhill
Back

Cullinan Therapeutics, Inc. 10K Form

Sell
42

CGEM
Cullinan Therapeutics, Inc.

Last Price:
$10.33
Seasonality Move:
11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CGEM News And Ratings

See the #1 stock for the next 7 days that we like better than CGEM

CGEM Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-36.9M
Price / Cash Flow: 0
Annual Sales: $7.64
Price / Book: 1.27

Profitability

EPS (TTM): -3.68060
Net Income (TTM): $-216.8M
Gross Margin: $-306K
Return on Equity: -39.95%
Return on Assets: -37.91%

Cullinan Therapeutics, Inc. Earnings Forecast

Key Cullinan Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 9 years have been positive in 2 years.

Cullinan Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CGEM
Website: cullinantherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 10.45
Quick Ratio: 10.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CGEM Technical Analysis vs Fundamental Analysis

Sell
42
Cullinan Therapeutics, Inc. (CGEM) is a Sell

Is Cullinan Therapeutics, Inc. a Buy or a Sell?